首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in aging neuroscience

缩写:FRONT AGING NEUROSCI

ISSN:1663-4365

e-ISSN:1663-4365

IF/分区:5.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引8125
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Minnuo Cai,Hang Lei,Yuetong Zhang et al. Minnuo Cai et al.
Background: Predicting patient-specific neurodegenerative trajectories is essential for targeted interventions in Alzheimer's disease. Although the APOE-ε4 allele is the predominant genetic risk factor for hippocampal at...
Shreyasi Majumdar,Puneet K Samaiya,Sahabuddin Ahmed et al. Shreyasi Majumdar et al.
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), represent a major global health burden. Imaging biomarkers have emerged...
Sunitha Subhramanian,Olga Bocharova,Olga Mychko et al. Sunitha Subhramanian et al.
Microglia maintain neuronal homeostasis through dynamic surveillance strategies that depend on their functional state. In the healthy brain, highly ramified microglia monitor neuronal integrity via motile processes and transient soma contac...
YongSoo Shim,Eun Ye Lim YongSoo Shim
Background: Facial emotion recognition (FER) is increasingly recognized as a functionally relevant domain in the Alzheimer's disease (AD) spectrum, yet whether baseline FER is associated with subsequent clinical decline r...
Diana Patricia Quijano-Guerrero,Ana Esther Estrada-Rodríguez,Mauricio Caballero-Rodríguez et al. Diana Patricia Quijano-Guerrero et al.
The buildup of toxic aggregates formed by the amyloid-β peptide 1-42 (Aβ42) is a central process in Alzheimer's disease (AD) pathology. The peptide's self-assembly and toxicity are highly dependent on its primary amino acid sequence and c...
Maor Yeshua,Elise Klein,Martin Südmeyer et al. Maor Yeshua et al.
Introduction: Parkinson's disease (PD) is characterized not only by motor symptoms but also by non-motor impairments, including deficits in social cognition (SC), defined as the ability to recognize, interpret, and respon...
Zhiwei Zhang,Yang Zhou Zhiwei Zhang
Parkinson's disease (PD) is the second most common neurodegenerative disorder, featuring progressive dopaminergic neuronal loss, Lewy body (LB) pathology, and a broad spectrum of motor and non-motor symptoms. Although dopaminergic pharmacot...
Ke Wang,Xiaoxuan Xing,Zhizhou Wang et al. Ke Wang et al.
Background: Generic pramipexole is widely prescribed for Parkinson's disease (PD), yet clinical equivalence to the brand-name formulation remains debated. We aimed to compare generic and brand-name pramipexole dihydrochlo...
Ho-Jong Gil,Jongbin Kim Ho-Jong Gil
Introduction: Early mild cognitive impairment (eMCI) is often accompanied by subtle alterations in motor function and gait control before the onset of overt dementia. Identifying these early functional changes may provide...